坚持和坚持使用前列腺素类似物治疗玻璃眼:系统性审查和元分析
Christophe Baudouin1, Jonathan S Myers2, Sarah H Van Tassel3
1From the INSERM-DGOS CIC 1423 (C.B.), Hôpital National des Quinze-Vingts, IHU FOReSIGHT, Paris, France; Institut de la Vision (C.B.), IHU FOReSIGHT, Sorbonne University and Versailles Saint Quentin - Paris Saclay University, Paris, France.
American journal of ophthalmology
|March 20, 2025
概括
玻璃眼患者表现出对前列腺素类似物 (PGAs) 的不良坚持和持久性,随着时间的推移,其率下降. 这凸显了非日常程序性治疗对治疗眼的潜在益处.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 玻璃眼是全球不可逆转的失明的主要原因.
- 前列腺素类似物 (PGAs) 是常见的局部药物,用于治疗青光眼.
- 患者对长期局部药物治疗方案的坚持和坚持往往不理想.
研究的目的:
- 系统地审查,综合和量化关于对PGAs的坚持和持久性的研究.
- 了解使用PGAs的青光眼患者的现实世界治疗行为.
- 在局部PGA和程序干预之间为治疗决策提供信息.
主要方法:
- 系统性文献综述 (SLR) 和观测研究的元分析 (MA).
- 包括报告成年青光眼患者坚持和持久性的客观测量研究.
- 对药物持有率 (MPR) 或药物持有率 (PDC) 的分析,用于治疗的坚持和持续时间.
主要成果:
- 分析包括47项研究,涉及96.1万名患者.
- 在第一年,对PGAs的平均遵守率为44%;在第一年,MPR/PDC的平均遵守率为54%,在第二年为60%.
- 持续使用PGAs的比例从6个月后的75%下降到3年后的31%.
结论:
- 对前列腺素类似物的低最佳坚持和持续性在玻璃眼患者中很普遍.
- 坚持和持久性随着治疗持续时间的延长而显著下降.
- 研究结果表明,程序性玻璃眼治疗可能比每日局部药物治疗有优势.
相关概念视频
Open Angle Glaucoma: Treatment
378
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
378
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
140
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
140
Glaucoma: Overview
486
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
486
Angle Closure Glaucoma: Treatment
417
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
417
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
324
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
324
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
441
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
441


